More extensive prospective studies and experimental research are necessary to illustrate the exact mechanisms underlying the role of RANKL in NAFLD, especially in non-obese PCOS patients. This evidence concerns the gene TNFSF11 and metabolic dysfunction-associated steatotic liver disease.